Delcath Systems Files 8-K: Regulation FD Disclosure
Ticker: DCTH · Form: 8-K · Filed: Aug 29, 2024 · CIK: 872912
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
DELCATH filed an 8-K on Aug 29 for an Aug 28 event - FD disclosure & financials.
AI Summary
Delcath Systems, Inc. filed an 8-K on August 29, 2024, reporting an event on August 28, 2024. The filing is a Regulation FD Disclosure and includes Financial Statements and Exhibits. The company's principal executive offices are located at 566 Queensbury Avenue, Queensbury, New York.
Why It Matters
This 8-K filing indicates Delcath Systems is disclosing important information under Regulation FD, which could impact how investors interpret recent company events and financial status.
Risk Assessment
Risk Level: low — This is a routine filing for a current report and does not inherently signal significant new risks.
Key Players & Entities
- DELCATH SYSTEMS, INC. (company) — Registrant
- August 28, 2024 (date) — Earliest event reported
- August 29, 2024 (date) — Filing date
- 566 Queensbury Avenue, Queensbury, New York 12804 (address) — Principal Executive Offices
FAQ
What specific event occurred on August 28, 2024, that necessitated this 8-K filing?
The filing indicates an event occurred on August 28, 2024, but the specific details of this event are not provided in the excerpt, only that it triggered a Regulation FD Disclosure and the filing of Financial Statements and Exhibits.
What is the significance of a 'Regulation FD Disclosure' in this filing?
A Regulation FD Disclosure means the company is making public any material non-public information that may have been disclosed to certain parties, ensuring fair and equal dissemination of information to all investors.
What types of financial statements and exhibits are included in this filing?
The excerpt states that 'Financial Statements and Exhibits' are included, but does not specify the exact nature or content of these documents.
What is Delcath Systems, Inc.'s primary business or industry?
Delcath Systems, Inc. is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' with SIC code 3841.
Where are Delcath Systems, Inc.'s principal executive offices located?
The company's principal executive offices are located at 566 Queensbury Avenue, Queensbury, New York 12804.
Filing Stats: 494 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-08-29 08:00:53
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value DCTH The Nasdaq Capital M
Filing Documents
- d848222d8k.htm (8-K) — 23KB
- d848222dex991.htm (EX-99.1) — 8KB
- 0001193125-24-209296.txt ( ) — 149KB
- dcth-20240828.xsd (EX-101.SCH) — 3KB
- dcth-20240828_lab.xml (EX-101.LAB) — 17KB
- dcth-20240828_pre.xml (EX-101.PRE) — 11KB
- d848222d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated August 28, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DELCATH SYSTEMS, INC. Date: August 29, 2024 By: /s/ Gerard Michel Name: Gerard Michel Title: Chief Executive Officer